Cargando…
The Tyrosine Kinase Inhibitor Sunitinib Affects Ovulation but Not Ovarian Reserve in Mouse: A Preclinical Study
The aim of the study was to evaluate ovarian toxicity of tyrosine kinase inhibitor (TKI) sunitinib, since only scarce data are available on gonadal function after this treatment. Six-week-old female mice received orally, once daily, vehicle or sunitinib (50 mg/kg/d) during 5 weeks. Fertility paramet...
Autores principales: | Bernard, Valérie, Bouilly, Justine, Kramer, Piet, Carré, Nadège, Schlumberger, Martin, Visser, Jenny A., Young, Jacques, Binart, Nadine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818017/ https://www.ncbi.nlm.nih.gov/pubmed/27035144 http://dx.doi.org/10.1371/journal.pone.0152872 |
Ejemplares similares
-
R-spondin2, a novel target of NOBOX: identification of variants in a cohort of women with primary ovarian insufficiency
por: Bouilly, Justine, et al.
Publicado: (2017) -
Effects of High Affinity Leptin Antagonist on Prolactin Receptor Deficient Male Mouse
por: Carré, Nadège, et al.
Publicado: (2014) -
A meta-analysis of threats to valid clinical inference in preclinical research of sunitinib
por: Henderson, Valerie C, et al.
Publicado: (2015) -
Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer
por: Brooks, Colin, et al.
Publicado: (2012) -
Prevention of Premature Ovulation by Administration of Gonadotropin Releasing Hormone Antagonist the day After Ovulation Triggering in Diminished Ovarian Reserve Patients
por: Sik, Bulat Aytek, et al.
Publicado: (2022)